Michael Pearson

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Former Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company

By
July 13, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s Former CEO Will Stay on as an $83,000-a-Month Consultant

By
May 31, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Ackman Bids Farewell to Man Who Pushed for Disastrous Valeant Investment

By
May 12, 2016
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
Finance

This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO

By
May 10, 2016
Coins2Day Global Forum 2015
Leadership

Meet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals

By
May 10, 2016
Squawk Box - Season 20
Finance

Bill Ackman: Valeant’s Drug Price Hikes Hurt America

By
April 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Valeant’s CEO Just Avoided Contempt Charges From the U.S. Senate

By
April 13, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Promises Company Won’t Go Bankrupt in Staff Memo

By
March 18, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Valeant Shares Plummeted Again

By
March 17, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s Shares Are Having An Epically Bad Day

By
March 15, 2016
Inside The 2016 Consumer Electronics Show
Finance

These Stock Market-Battered Execs Just Became Ex-Billionaires

By
January 26, 2016
valeant ceo michael pearson
Leadership

Valeant’s CEO Isn’t Sure When He’ll Return from Medical Leave

By
January 25, 2016
Janet Yellen Testifies Before House Financial Services Committee
Finance

End of Easy Money Brings Relief

By
December 17, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant accounting scandal: 4 critical questions that have been left unanswered

By
October 26, 2015

Most Popular